STUDY OF HYDROXYUREA MECHANISMS OF ACTION ON LEUKOCYTE ACTIVATION IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE SYNDROMES.

Trial Profile

STUDY OF HYDROXYUREA MECHANISMS OF ACTION ON LEUKOCYTE ACTIVATION IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE SYNDROMES.

Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Jul 2013

At a glance

  • Drugs Hydroxycarbamide (Primary)
  • Indications Myeloproliferative disorders
  • Focus Pharmacodynamics
  • Most Recent Events

    • 06 Jun 2013 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
    • 15 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top